Immediate Impact
73 standout
Citing Papers
Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement
2022 Standout
Challenges of Sarcoidosis and Its Management
2021 Standout
Works of Norbert Klause being referenced
Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor
2010
Analysis of immunoglobulins in sarcoidosis.
1997
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Norbert Klause | 8 | 10 | 11 | 313 | 240 | 16 | 450 | |
| C. Dansirikul | 19 | 277 | 138 | 12 | 473 | |||
| D E Jewitt | 21 | 11 | 347 | 110 | 14 | 491 | ||
| Christopher N. Floyd | 19 | 11 | 2 | 315 | 88 | 30 | 485 | |
| Christine Gaud | 5 | 9 | 2 | 280 | 109 | 10 | 487 | |
| D Fitzgerald | 14 | 29 | 241 | 89 | 16 | 400 | ||
| Bruno Boutouyrie | 14 | 3 | 239 | 251 | 15 | 421 | ||
| Joanna Sikora | 3 | 2 | 369 | 119 | 37 | 479 | ||
| H A Cameron | 31 | 8 | 164 | 59 | 14 | 411 | ||
| Nina Vene | 14 | 1 | 324 | 151 | 26 | 460 | ||
| Mirella Frascaro | 26 | 12 | 44 | 126 | 180 | 13 | 411 |
All Works
Loading papers...